ROLE OF THE C-TERMINUS GAG PROTEIN IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRION ASSEMBLY AND MATURATION

被引:44
|
作者
FU, XY
MATSUDA, Z
YU, QC
LEE, TH
ESSEX, M
机构
[1] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT MOLEC MICROBIOL & IMMUNOL,BALTIMORE,MD 21205
[2] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115
[3] UNIV CHICAGO,DEPT MOLEC GENET & CELL BIOL,CHICAGO,IL 60637
来源
关键词
D O I
10.1099/0022-1317-76-12-3171
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lentiviral Gag polyproteins have a proline-rich protein, p6, at their C terminus. There are conflicting reports about the function of p6 in virus release. In the present work, mutants that affect p6 of human immunodeficiency virus type 1 (HIV-1) Gag polyprotein were constructed and analysed. None of the mutants prevented virus release completely; however, detachment of budding particles was less efficient as evidenced by electron microscopy. Virions of the p6 truncation mutant B2TAA had a significantly reduced number of Pol proteins (p66, p51 and p34) and an increased amount of incompletely processed Gag proteins compared with the parental virus. A mutation that altered the cleavage site between p6 and p1 did not significantly affect virus assembly, virus release or protein processing with the exception of cleavage between p6 and p1. However, virions of this mutant (B2P6C) exhibited irregular-shaped core structures that were distinct from the con-shaped core structure seen in the parental virion. B2P6C mutant virus was non-infectious in CD4(+) T cells. These results suggest that mutations in p6 affect efficient detachment of budding particles from the cell surface. Proper cleavage between p6 and p1 may be critical for the formation of the distinctive cone-shaped core structure of HIV-1 virions.
引用
收藏
页码:3171 / 3179
页数:9
相关论文
共 50 条
  • [21] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [22] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [23] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [24] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [25] A SIMPLE METHOD FOR OVERPRODUCTION AND PURIFICATION OF P24 GAG PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TANAKA, N
    SAITOH, A
    NAKATA, A
    SHINAGAWA, H
    MICROBIOLOGY AND IMMUNOLOGY, 1992, 36 (08) : 823 - 831
  • [26] INHIBITION OF INFECTIOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLE FORMATION BY GAG PROTEIN-DERIVED PEPTIDES
    NIEDRIG, M
    GELDERBLOM, HR
    PAULI, G
    MARZ, J
    BICKHARD, H
    WOLF, H
    MODROW, S
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 1469 - 1474
  • [27] MORPHOGENIC CAPABILITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG AND GAG-POL PROTEINS IN INSECT CELLS
    HUGHES, BP
    BOOTH, TF
    BELYAEV, AS
    MCILROY, D
    JOWETT, J
    ROY, P
    VIROLOGY, 1993, 193 (01) : 242 - 255
  • [28] A VIRION-SPECIFIC INHIBITORY MOLECULE WITH THERAPEUTIC POTENTIAL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MATSUDA, Z
    YU, XF
    YU, QC
    LEE, TH
    ESSEX, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3544 - 3548
  • [29] INCORPORATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG PROTEINS INTO MURINE LEUKEMIA-VIRUS VIRIONS
    DEMINIE, CA
    EMERMAN, M
    JOURNAL OF VIROLOGY, 1993, 67 (11) : 6499 - 6506
  • [30] FUNCTIONAL DOMAINS OF THE CAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    DORFMAN, T
    BUKOVSKY, A
    OHAGEN, A
    HOGLUND, S
    GOTTLINGER, HG
    JOURNAL OF VIROLOGY, 1994, 68 (12) : 8180 - 8187